Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.

Cross-talk between the estrogen and the EGFR/HER signalling pathways has been suggested as a potential cause of resistance to endocrine therapy in breast cancer. Here, we determined HER1-4 receptor and neuregulin-1 (NRG1) ligand mRNA expression levels in breast cancers and corresponding normal breas...

Full description

Bibliographic Details
Main Authors: Marianne Hauglid Flågeng, Stian Knappskog, Ben P Haynes, Per Eystein Lønning, Gunnar Mellgren
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3750010?pdf=render